HomeCompareFLCEX vs JNJ

FLCEX vs JNJ: Dividend Comparison 2026

FLCEX yields 9.54% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FLCEX wins by $17.6K in total portfolio value
10 years
FLCEX
FLCEX
● Live price
9.54%
Share price
$20.97
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.6K
Annual income
$1,738.36
Full FLCEX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FLCEX vs JNJ

📍 FLCEX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFLCEXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FLCEX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FLCEX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FLCEX
Annual income on $10K today (after 15% tax)
$810.68/yr
After 10yr DRIP, annual income (after tax)
$1,477.61/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, FLCEX beats the other by $773.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FLCEX + JNJ for your $10,000?

FLCEX: 50%JNJ: 50%
100% JNJ50/50100% FLCEX
Portfolio after 10yr
$28.8K
Annual income
$1,283.07/yr
Blended yield
4.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FLCEX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FLCEX buys
0
JNJ buys
0
No recent congressional trades found for FLCEX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFLCEXJNJ
Forward yield9.54%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$37.6K$20.0K
Annual income after 10y$1,738.36$827.78
Total dividends collected$13.5K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FLCEX vs JNJ ($10,000, DRIP)

YearFLCEX PortfolioFLCEX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,654$953.74$10,676$355.77+$978.00FLCEX
2$13,508$1,038.76$11,407$389.39+$2.1KFLCEX
3$15,579$1,125.29$12,198$426.53+$3.4KFLCEX
4$17,883$1,212.90$13,056$467.62+$4.8KFLCEX
5$20,435$1,301.15$13,987$513.12+$6.4KFLCEX
6$23,256$1,389.63$14,998$563.56+$8.3KFLCEX
7$26,361$1,477.94$16,098$619.52+$10.3KFLCEX
8$29,772$1,565.72$17,295$681.69+$12.5KFLCEX
9$33,509$1,652.63$18,599$750.82+$14.9KFLCEX
10$37,593$1,738.36$20,022$827.78+$17.6KFLCEX

FLCEX vs JNJ: Complete Analysis 2026

FLCEXStock

The investment seeks capital appreciation. The fund normally invests at least 80% of assets in common stocks included in the S&P 500® Index, which is a market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance. It invests in domestic and foreign issuers.

Full FLCEX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FLCEX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FLCEX vs SCHDFLCEX vs JEPIFLCEX vs OFLCEX vs KOFLCEX vs MAINFLCEX vs ABBVFLCEX vs MRKFLCEX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.